Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlas Metals Group PLC Regulatory News (AMG)

Share Price Information for Atlas Metals Group PLC (AMG)

Share Price is delayed by 15 minutes
Get Live Data
8.00    -1.00 (-11.11%)
Bid:
7.50
Ask:
8.50
Spread: 1.00 (13.333%)
Market Cap: £3.40m
AMG Live PriceLast checked at - London Stock Exchange

Intraday Atlas Metals Group PLC Share Chart

Issue of Equity

31 Mar 2026 15:45

RNS Number : 9024Y
Atlas Metals Group PLC
31 March 2026
 

31 March 2026

Atlas Metals Group plc

("Atlas Metals" or the "Company")

 

Issue of equity

 

Atlas Metals (LON: AMG), the natural resources and energy company announces that application has been made to London Stock Exchange plc (the "London Stock Exchange") for the admission of 648,497 ordinary shares of nominal value £0.01 each ("Ordinary Shares") to be admitted to trading on the main market for listed securities of the London Stock Exchange ("Admission").

Admission relates to the allotment of 648,497 new Ordinary Shares ("New Shares") to be issued to a third party in full and final settlement of a contractual claim against the Company, calculated by reference to the average prevailing 5-day volume-weighted average price of Ordinary Shares for the period ending 23 March 2026, being 7.71 pence.

Admission of the New Shares is expected to occur on 1 April 2026. The New Shares will rank pari passu in all respects with the existing Ordinary Shares.

Following Admission, the Company's issued ordinary share capital will comprise 39,181,427 Ordinary Shares, each carrying one vote. The Company does not hold any Ordinary Shares in treasury. The total number of voting rights in the Company following Admission will therefore be 39,181,427. With effect from Admission, this figure may be used by shareholders as the denominator for the calculations by which they determine whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

Atlas Metals Group plc:

Christopher Chadwick

+44 (0) 207 796 9060

Strand Hanson - Financial Adviser and Sponsor:

Rory Murphy

+44 (0) 207 409 1761

Abigail Wennington

+44 (0) 207 409 1761

Edward Foulkes

+44 (0) 207 409 1761

S I Capital Limited - Joint Broker:

Nick Emerson

+44 (0) 1483 413500

CMC Markets - Joint Broker:

Douglas Crippen

+44 (0) 20 3003 8632

Axis Capital Markets Limited - Joint Broker:

Richard Hutchison

+44 (0) 20 3026 0320

IFC Advisory Limited - Financial PR and IR:

Tim Metcalfe

+44 (0) 203 934 6632

Florence Staton

+44 (0) 203 934 6632

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESDMFLFEMSESD
12
Date   Source Headline
3rd Jun 202612:53 pmRNSResult of AGM
26th May 20264:01 pmRNSIssue of New Ordinary Shares & Total Voting Rights
11th May 20262:09 pmRNSReplacement: Notice of Annual General Meeting
11th May 202612:32 pmRNSNotice of Annual General Meeting
30th Apr 20265:22 pmRNSFinal results for the year ended 31 December 2025
20th Apr 20267:00 amRNSUpdate on Funding Facility & Change of Auditor
2nd Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20263:45 pmRNSIssue of Equity
19th Mar 20263:38 pmRNSPDMR Dealing
18th Mar 20262:57 pmRNSIssue of New Ordinary Shares & Total Voting Rights
18th Mar 20261:09 pmRNSPDMR Dealing
13th Mar 202612:27 pmRNSHolding(s) in Company
10th Mar 20262:33 pmRNSHolding(s) in Company
5th Mar 202612:30 pmRNS-RUPSA Update
5th Mar 20267:00 amRNSFunding Facility of up to £2.5 million
2nd Mar 20265:13 pmRNSTotal Voting Rights
20th Feb 20262:00 pmRNSHolding(s) in Company
19th Feb 20263:18 pmRNSIssue of Equity
16th Feb 20267:00 amRNS-RUpdate on Proposed Acquisition
11th Feb 202611:04 amRNSHolding(s) in Company
9th Feb 20267:00 amRNS-RUpdate on Kyrgyz Uranium Asset
4th Feb 20267:00 amRNSATM Facility, Share Issues and TVR Update
3rd Feb 202612:10 pmRNSHolding(s) in Company
2nd Feb 20268:56 amRNSHolding(s) in Company
2nd Feb 20268:49 amRNSHolding(s) in Company
2nd Feb 20268:49 amRNSHolding(s) in Company
16th Jan 20264:02 pmRNSHolding(s) in Company
13th Jan 202611:18 amRNSHolding(s) in Company
12th Jan 202612:48 pmRNSHolding(s) in Company
7th Jan 20261:08 pmRNSHolding(s) in Company
6th Jan 20261:40 pmRNSHolding(s) in Company
24th Dec 202510:53 amRNSHolding(s) in Company
24th Dec 202510:48 amRNSHolding(s) in Company
22nd Dec 20257:00 amRNSUpdate on Proposed Acquisition
17th Dec 20254:07 pmRNSPlacing, exercise of warrants, Director's Dealing
8th Dec 20251:59 pmRNSIssue of new Ordinary Shares, exercise of warrants
1st Dec 202512:43 pmRNSResults of General Meeting
28th Nov 20257:00 amRNSUpdated Competent Persons Report published
5th Nov 20254:01 pmRNSPublication of Circular & Notice of GM
28th Oct 20257:00 amRNSAppointment of Financial Adviser and Sponsor
30th Sep 20257:00 amRNSInterim Results
17th Sep 202511:49 amRNSHolding(s) in Company
10th Sep 20257:00 amRNSUpdate on Proposed Acquisition of UPSA
17th Jun 20255:15 pmRNSResult of AGM
17th Jun 20257:00 amRNSProposed Acquisition of UPSA and Corporate Update
23rd May 20257:00 amRNSNotice of AGM
30th Apr 20255:39 pmRNSFinal Results
30th Apr 20257:00 amRNSAppointment of Non-Executive Director
6th Feb 20257:00 amRNSDirectorate Change
17th Jan 20257:00 amRNSCorporate Update
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.